Cygnus Biosciences

company

About

Cygnus Biosciences is a Chinese gene sequencing company.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$19.60M
Industries
Biotechnology,Clinical Trials,Health Diagnostics,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Cygnus Biosciences (Beijing) Co., Ltd. is a high-tech company specializing in R & D and industrialization of gene sequencing platform and committed to clinical medicine screening and diagnosis.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$19.60M
Cygnus Biosciences has raised a total of $19.60M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 14, 2017 Series B $19.60M 2 Detail
Aug 28, 2015 Series A 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Cygnus Biosciences is funded by 2 investors. Jinggong Hongyuan and General Technology Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Jinggong Hongyuan Series B
General Technology Venture Capital Series B